Eli Lilly Prevails in Suit Against HHS Over 340B Drug Price Program

A federal judge has ruled that HHS acted incorrectly in warning drugmakers that ending discounts via the 340B Drug Price Program would constitute a violation of the law.
Source: Drug Industry Daily